...
首页> 外文期刊>Journal of the American Society of Nephrology: JASN >Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo.
【24h】

Xenobiotic kidney organogenesis from human mesenchymal stem cells using a growing rodent embryo.

机译:使用正在生长的啮齿动物胚胎从人间充质干细胞产生异种肾器官。

获取原文
获取原文并翻译 | 示例

摘要

Given the limits of allogenic organ transplantation, an ultimate therapeutic solution is to establish a self-organ from autologous stem cells and transplant them as syngrafts back into donor patients. It was reported previously that human mesenchymal stem cells (hMSC) that are cultivated in growing rodent embryos can differentiate within a spatially and temporally appropriate developmental milieu, facilitating the first step of nephrogenesis. As another step toward clinical application, the system was modified for progression to complete functional organogenesis. Rat embryos (E11.5) were isolated from uteri, and bone marrow-derived hMSC, which were transfected adenovirally with glial cell line-derived neurotrophic factor and retrovirally with LacZ, were implanted into the nephrogenic site. Forty-eight hours later, ureteric buds were elongated and initial branching was completed. The metanephroi were dissected out, developed further using in vitro organ culture for 24 h, transplanted into the omentum ofa uninephrectomized rat, and grown for 2 wk. They enlarged and exhibited normal kidney structure and ultrastructure. hMSC-derived LacZ-positive cells were identified throughout the regenerated kidney and were morphologically identical to resident renal cells. Transplantation of developing metanephroi into the LacZ transgenic rat revealed that neo-kidney vasculature originated from the host circulation. Finally, fluid was collected from expanded ureters, and urea nitrogen and creatinine were measured. Levels were much higher in these fluids compared with transplanted rat sera (840.3 +/- 184.6 versus 30.4 +/- 10.8 and 10.1 +/- 3.1 versus 0.3 +/- 0.2 mg, respectively), suggesting that the neo-kidney may produce urine. Taken together, these findings suggest that hMSC can differentiate into a mature renal structure with the potential to replace lost kidney function.
机译:鉴于同种异体器官移植的局限性,一种最终的治疗方案是从自体干细胞建立一种自体器官,并将其作为同种异体移植回供体患者中。以前有报道说,在生长的啮齿动物胚胎中培养的人间充质干细胞(hMSC)可以在空间和时间上适当的发育环境中分化,从而促进了肾生成的第一步。作为迈向临床应用的又一步,对系统进行了修改,以使其发展为完成功能器官的过程。从子宫中分离出大鼠胚胎(E11.5),并将用胶质细胞源性神经营养因子经腺病毒转染并用LacZ逆转录病毒的骨髓源hMSC植入肾原位。 48小时后,输尿管芽被拉长,初始分支完成。解剖后肾,用体外器官培养进一步发展24小时,移植到未切除直肠的大鼠的大网膜中,并生长2周。它们扩大并显示出正常的肾脏结构和超微结构。 hMSC来源的LacZ阳性细胞在整个再生肾脏中都得到了鉴定,并且在形态上与常驻肾细胞相同。发育中的肾移植到LacZ转基因大鼠中表明,新肾的脉管系统起源于宿主循环。最后,从扩张的输尿管中收集液体,并测量尿素氮和肌酐。与移植的大鼠血清相比,这些液体的水平要高得多(分别为840.3 +/- 184.6和30.4 +/- 10.8和10.1 +/- 3.1和0.3 +/- 0.2 mg),表明新肾可能会产生尿液。综上所述,这些发现表明,hMSC可以分化成成熟的肾结构,并有可能替代失去的肾功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号